Form 4: Geno Germano Executes Stock Transaction in Precision BioSciences
SEC Form 4 Filing
Director Geno Germano reports the vesting and settlement of Restricted Stock Units (RSUs) into Precision BioSciences common stock on May 4, 2024.
Summary
- On May 4, 2024, Geno Germano, a director of Precision BioSciences, Inc. (DTIL), vested and settled 4,202 Restricted Stock Units (RSUs) into common stock.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The RSUs vested in full on May 4, 2024.
- The amounts of securities herein have been adjusted to reflect the 1-for-30 reverse stock split that took place on February 13, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 02/13/2024 | Issuer effected a 1-for-30 reverse stock split. |
| 05/04/2023 | Reporting Person was granted RSUs. |
| 05/04/2024 | RSUs vested in full and were settled. |
| 05/07/2024 | Date of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.